Beta Bionics, Inc. Common Stock BBNX Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$66.44M+6.4% | -$73.2M-33.7% | -$77.84M-63.3% | -$73.37M-49.9% | -$70.96M-55.9% | ||
| $1.86M+59.0% | $1.57M+36.7% | $1.27M+3.4% | $1.22M+1.3% | $1.17M-3.3% | ||
| $18.99M+142% | $16.38M+157% | $13.63M+118% | $11.13M+95.8% | $7.83M+39.8% | ||
| -$54.78M+2.4% | -$50.93M-5.5% | -$56.58M-34.4% | -$57.46M-41.5% | -$56.1M-53.8% | ||
| $6.34M+90.9% | $5.3M+56.0% | $3.96M+34.8% | $4.59M+312% | $3.32M+370% | ||
| —— | —— | —— | —— | -$190.24M-326% | ||
| $4.38M-98.4% | $214.87M+286% | $270.71M+1,029% | $266.88M+429% | $266.73M+252% | ||
| —— | —— | —— | —— | $20.38M+483% | ||
| -$61.12M-2.9% | -$56.22M-8.8% | -$60.53M-34.4% | -$62.06M-48.8% | -$59.43M-59.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Beta Bionics, Inc. Common Stock generate?
- Beta Bionics, Inc. Common Stock (BBNX) generated -$54.8M in operating cash flow over the trailing twelve months.
- What is Beta Bionics, Inc. Common Stock's free cash flow?
- After $6.3M of capital expenditures, Beta Bionics, Inc. Common Stock's free cash flow was -$61.1M over the trailing twelve months, down 2.9% year over year.
- Where does Beta Bionics, Inc. Common Stock's cash flow data come from?
- Every line is extracted from Beta Bionics, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
